BR112014007022A8 - composição farmacêutica, método de melhoria da absorção no intestino delgado e uso de uma composição farmacêutica. - Google Patents
composição farmacêutica, método de melhoria da absorção no intestino delgado e uso de uma composição farmacêutica.Info
- Publication number
- BR112014007022A8 BR112014007022A8 BR112014007022A BR112014007022A BR112014007022A8 BR 112014007022 A8 BR112014007022 A8 BR 112014007022A8 BR 112014007022 A BR112014007022 A BR 112014007022A BR 112014007022 A BR112014007022 A BR 112014007022A BR 112014007022 A8 BR112014007022 A8 BR 112014007022A8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- small intestine
- improving absorption
- absorption
- improving
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 238000010521 absorption reaction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000000813 small intestine Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161538028P | 2011-09-22 | 2011-09-22 | |
| US61/538,028 | 2011-09-22 | ||
| US13/625,652 US20130209577A1 (en) | 2011-09-22 | 2012-09-24 | Buffered Upper GI Absorption Promoter |
| PCT/US2012/056944 WO2013044246A1 (en) | 2011-09-22 | 2012-09-24 | Buffered upper gi absorption promoter |
| US13/625,652 | 2012-09-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112014007022A2 BR112014007022A2 (pt) | 2017-04-25 |
| BR112014007022A8 true BR112014007022A8 (pt) | 2018-01-09 |
| BR112014007022B1 BR112014007022B1 (pt) | 2021-02-09 |
Family
ID=47914954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014007022-9A BR112014007022B1 (pt) | 2011-09-22 | 2012-09-24 | composição farmacêutica, método e uso de uma composição farmacêutica |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130209577A1 (pt) |
| AU (4) | AU2012311964B2 (pt) |
| BR (1) | BR112014007022B1 (pt) |
| CA (1) | CA2849732C (pt) |
| MX (1) | MX2014003327A (pt) |
| WO (1) | WO2013044246A1 (pt) |
| ZA (1) | ZA201402197B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015016660A (es) | 2013-06-06 | 2016-07-26 | Amip Llc | Complemento de hierro. |
| GB201416293D0 (en) * | 2014-09-15 | 2014-10-29 | Solvotrin Therapeutics Ltd | Methods and preparations |
| IL261735B (en) * | 2016-03-15 | 2022-07-01 | Solvotrin Therapeutics Ltd | Preparations and methods for increasing iron absorption in mammals |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716814B2 (en) * | 2001-08-16 | 2004-04-06 | Albion International, Inc. | Enhancing solubility of iron amino acid chelates and iron proteinates |
| US7371422B2 (en) * | 2003-05-13 | 2008-05-13 | The Procter & Gamble Company | Cereal grain kernels fortified with iron and calcium |
| US20090035385A1 (en) * | 2004-12-22 | 2009-02-05 | Drugtech Corporation | Compositions including iron |
| US20060134227A1 (en) | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
| US8007846B2 (en) * | 2006-01-18 | 2011-08-30 | Albion International, Inc. | Mixed amino acid/mineral compounds having improved solubility |
| WO2008042218A1 (en) * | 2006-10-03 | 2008-04-10 | Tris Pharma, Inc. | Formulations containing an ionic mineral-ion exchange resin complex and uses thereof |
| ITMI20071979A1 (it) * | 2007-10-12 | 2009-04-13 | Massimo Baldacci | Formulazioni farmaceutiche contenenti ferro bisglicinato chelato |
| US20090124572A1 (en) * | 2007-11-09 | 2009-05-14 | Deanna Jean Nelson | Iron-containing nutritional supplement |
| IT1398291B1 (it) * | 2009-12-16 | 2013-02-22 | Baldacci Lab Spa | Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci. |
-
2012
- 2012-09-24 WO PCT/US2012/056944 patent/WO2013044246A1/en active Application Filing
- 2012-09-24 AU AU2012311964A patent/AU2012311964B2/en active Active
- 2012-09-24 MX MX2014003327A patent/MX2014003327A/es unknown
- 2012-09-24 CA CA2849732A patent/CA2849732C/en active Active
- 2012-09-24 BR BR112014007022-9A patent/BR112014007022B1/pt active IP Right Grant
- 2012-09-24 US US13/625,652 patent/US20130209577A1/en not_active Abandoned
-
2014
- 2014-03-25 ZA ZA2014/02197A patent/ZA201402197B/en unknown
-
2016
- 2016-12-20 AU AU2016277587A patent/AU2016277587B2/en active Active
-
2018
- 2018-12-24 AU AU2018286568A patent/AU2018286568B2/en active Active
-
2020
- 2020-11-26 AU AU2020277247A patent/AU2020277247B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2849732C (en) | 2019-10-01 |
| AU2012311964A1 (en) | 2013-05-02 |
| AU2016277587A1 (en) | 2017-01-12 |
| US20130209577A1 (en) | 2013-08-15 |
| AU2012311964B2 (en) | 2016-09-22 |
| WO2013044246A1 (en) | 2013-03-28 |
| MX2014003327A (es) | 2014-07-09 |
| AU2018286568B2 (en) | 2020-09-03 |
| AU2018286568A1 (en) | 2019-01-24 |
| AU2020277247B2 (en) | 2023-01-05 |
| CA2849732A1 (en) | 2013-03-28 |
| AU2020277247A1 (en) | 2020-12-24 |
| ZA201402197B (en) | 2015-11-25 |
| AU2016277587B2 (en) | 2018-10-04 |
| BR112014007022B1 (pt) | 2021-02-09 |
| BR112014007022A2 (pt) | 2017-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269858A (en) | Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof | |
| EP2746283A4 (en) | PYRIMIDOPYRIMIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
| BR112015002541A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente. | |
| BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
| IL217224B (en) | Pyrazolopyrimides, pharmaceutical preparations containing them and their use | |
| BR112014010290A2 (pt) | composição farmacêutica, métodos, composições e usos | |
| IL232914A0 (en) | New Azetidine histories, pharmaceutical preparations and their uses | |
| DK2742019T3 (da) | N1-cyklisk amin-n5-substituerede phenylbiguanidderivater og farmaceutisk sammensætning, der omfatter disse | |
| BR112014012005A2 (pt) | composições, métodos, formulação farmacêutica e artigo | |
| BR112014031412A2 (pt) | método de preparação de uma composição, composição e seu uso, e kit. | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BRPI1010617A2 (pt) | uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição. | |
| BR112013003536A2 (pt) | composição, e utilização de uma composição. | |
| IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| IL236057B (en) | History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them | |
| EP2562172A4 (en) | SPHAELACTON DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION AND THEIR USE | |
| BRPI0915527A2 (pt) | pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos | |
| CL2014003525A1 (es) | Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension. | |
| BR112013014189A8 (pt) | composição farmacêutica, uso de um agente de potencialização e uso de uma composição | |
| BR112014026873A2 (pt) | método cosmético, composição cosmética e uso. | |
| EP3037099A4 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| EP2786982A4 (en) | AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/09/2012, OBSERVADAS AS CONDICOES LEGAIS. |